These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12036941)

  • 1. Splice variants but not mutations of DNA polymerase beta are common in bladder cancer.
    Thompson TE; Rogan PK; Risinger JI; Taylor JA
    Cancer Res; 2002 Jun; 62(11):3251-6. PubMed ID: 12036941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
    Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
    Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
    Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of hMSH2 and DNA polymerase beta genes in breast carcinomas and fibroadenomas.
    Bhattacharyya N; Chen HC; Grundfest-Broniatowski S; Banerjee S
    Biochem Biophys Res Commun; 1999 Jun; 259(2):429-35. PubMed ID: 10362525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hSmad5 gene, a human hSmad family member: its full length cDNA, genomic structure, promoter region and mutation analysis in human tumors.
    Gemma A; Hagiwara K; Vincent F; Ke Y; Hancock AR; Nagashima M; Bennett WP; Harris CC
    Oncogene; 1998 Feb; 16(7):951-6. PubMed ID: 9484787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA polymerase beta gene mutations in human bladder cancer.
    Matsuzaki J; Dobashi Y; Miyamoto H; Ikeda I; Fujinami K; Shuin T; Kubota Y
    Mol Carcinog; 1996 Jan; 15(1):38-43. PubMed ID: 8561864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for mutation of B-RAF in urothelial carcinomas of the bladder and upper urinary tract.
    Stoehr R; Brinkmann A; Filbeck T; Gamper C; Wild P; Blaszyk H; Hofstaedter F; Knuechel R; Hartmann A
    Oncol Rep; 2004 Jan; 11(1):137-41. PubMed ID: 14654916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reported in vivo splice-site mutations in the factor IX gene: severity of splicing defects and a hypothesis for predicting deleterious splice donor mutations.
    Ketterling RP; Drost JB; Scaringe WA; Liao DZ; Liu JZ; Kasper CK; Sommer SS
    Hum Mutat; 1999; 13(3):221-31. PubMed ID: 10090477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer.
    van Tilborg AA; de Vries A; Zwarthoff EC
    J Pathol; 2001 May; 194(1):76-80. PubMed ID: 11329144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
    Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
    Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porcine T-cell receptor beta-chain: a genomic sequence covering Dbeta1.1 to Cbeta2 gene segments and the diversity of cDNA expressed in piglets including novel alternative splicing products.
    Watanabe M; Iwasaki Y; Mita Y; Ota S; Yamada S; Shimizu M; Takagaki Y
    Mol Immunol; 2007 Mar; 44(9):2332-43. PubMed ID: 17118451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns.
    Miyake H; Hara I; Kamidono S; Eto H
    J Urol; 2004 Sep; 172(3):1127-9. PubMed ID: 15311055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation spectrum of the 9q34 tuberous sclerosis gene TSC1 in transitional cell carcinoma of the bladder.
    Knowles MA; Habuchi T; Kennedy W; Cuthbert-Heavens D
    Cancer Res; 2003 Nov; 63(22):7652-6. PubMed ID: 14633685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
    Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissues.
    Pepe CM; Saraco NI; Baquedano MS; Guercio G; Vaiani E; Marino R; Pandey AV; Flück CE; Rivarola MA; Belgorosky A
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):698-705. PubMed ID: 17608756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss.
    Adams J; Williams SV; Aveyard JS; Knowles MA
    Cancer Res; 2005 Jan; 65(1):66-75. PubMed ID: 15665280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths.
    Eng L; Coutinho G; Nahas S; Yeo G; Tanouye R; Babaei M; Dörk T; Burge C; Gatti RA
    Hum Mutat; 2004 Jan; 23(1):67-76. PubMed ID: 14695534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.